NAS:TPTX (USA)
Turning Point Therapeutics Inc $ 117.91 1 (0.86%)
Volume:
274,586
Avg Vol (1m):
253,889
Market Cap $:
5.68 Bil
Enterprise Value $:
4.97 Bil
PE Ratio:
0.00
PB Ratio:
7.09
Financial Strength | 7/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 171.67 | ||
Equity-to-Asset | 0.97 | ||
Debt-to-Equity | 0.01 | ||
Debt-to-EBITDA | -0.03 | ||
Altman Z-Score | 148.03 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -547.85 | ||
Net Margin % | -523.5 | ||
ROE % | -24.99 | ||
ROA % | -24.19 | ||
ROC (Joel Greenblatt) % | -2033.04 |
TPTX
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 7.09 | ||
PS Ratio | 198.84 | ||
EV-to-EBIT | -36.31 | ||
EV-to-EBITDA | -36.94 | ||
EV-to-Revenue | 198.91 | ||
Current Ratio | 35.45 | ||
Quick Ratio | 35.45 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 7.09 | ||
Earnings Yield (Greenblatt) % | -2.75 |